by Zaina Hamza: For Complete Post, Click Here…
A fourth of patients maintained deep remission at 1 year in small randomized trial in India.
Multidonor fecal microbiota transplantation coupled with an anti-inflammatory diet (FMT-AID) induced remissions in patients with mild-to-moderate ulcerative colitis when added to standard medical therapy, a randomized trial in India found.
In a modified intention-to-treat analysis involving 66 patients, 65.7% of those in the FMT-AID group had a clinical response at 8 weeks compared with 35.5% of those assigned to optimized standard medical therapy alone (OR 3.5, 95% CI 1.3-9.6, P=0.01), reported Vineet Ahuja, MD, DM, of the All India Institute of Medical Sciences in New Delhi, and colleagues.
